Lund, Sweden

Nikolina Barchan

This inventor holds 1 USPTO granted patent. Top assignees: Croda International, Inc., Enza Biotech Ab. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Nikolina Barchan

Introduction

Nikolina Barchan is a notable inventor based in Lund, Sweden. She has made significant contributions to the field of surfactant preparation processes. Her work focuses on the enzymatic production of alkyl polyglycosides, which are essential in various applications, particularly in health care formulations.

Latest Patents

Nikolina holds a patent for a surfactant preparation process. This innovative method involves an enzymatic process for creating C16 and C18 alkyl polyglycosides. The process entails reacting C16 and/or C18 alkyl glycosides with a glycosyl donor containing monosaccharide residues. This reaction forms an alkyl polyglycoside intermediate that can be fractionated to yield a final product. The resulting C16/C18 alkyl polyglycoside is particularly beneficial in health care formulations, especially as a solubilizer for active pharmaceutical ingredients (APIs). She has 1 patent to her name.

Career Highlights

Throughout her career, Nikolina has worked with prominent companies such as Enza Biotech AB and Croda International, Inc. Her experience in these organizations has allowed her to refine her expertise in surfactant technology and its applications in various industries.

Collaborations

Nikolina has collaborated with talented individuals, including Stefan Ulvenlund and Maria Andersson. These partnerships have contributed to her innovative work and the advancement of surfactant preparation processes.

Conclusion

Nikolina Barchan's contributions to the field of surfactant preparation highlight her innovative spirit and dedication to advancing health care formulations. Her patent and collaborations reflect her commitment to improving the efficacy of active pharmaceutical ingredients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…